PL2098526T3 - Bicykliczne związki zawierające azot aktywne w stanach przewlekłego bólu - Google Patents

Bicykliczne związki zawierające azot aktywne w stanach przewlekłego bólu

Info

Publication number
PL2098526T3
PL2098526T3 PL08101879T PL08101879T PL2098526T3 PL 2098526 T3 PL2098526 T3 PL 2098526T3 PL 08101879 T PL08101879 T PL 08101879T PL 08101879 T PL08101879 T PL 08101879T PL 2098526 T3 PL2098526 T3 PL 2098526T3
Authority
PL
Poland
Prior art keywords
nitrogen
chronic pain
pain conditions
bicyclic compounds
compounds active
Prior art date
Application number
PL08101879T
Other languages
English (en)
Inventor
Carla Ghelardini
Marisa Martinelli
Carlo Parini
Silvano Ronzoni
Original Assignee
Neurotune Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurotune Ag filed Critical Neurotune Ag
Publication of PL2098526T3 publication Critical patent/PL2098526T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL08101879T 2008-02-22 2008-02-22 Bicykliczne związki zawierające azot aktywne w stanach przewlekłego bólu PL2098526T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08101879.8A EP2098526B1 (en) 2008-02-22 2008-02-22 Nitrogen-containing bicyclic compounds active on chronic pain conditions

Publications (1)

Publication Number Publication Date
PL2098526T3 true PL2098526T3 (pl) 2014-06-30

Family

ID=39472460

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08101879T PL2098526T3 (pl) 2008-02-22 2008-02-22 Bicykliczne związki zawierające azot aktywne w stanach przewlekłego bólu

Country Status (17)

Country Link
US (1) US8334286B2 (pl)
EP (1) EP2098526B1 (pl)
JP (1) JP5400804B2 (pl)
CN (1) CN101945876B (pl)
AR (1) AR070465A1 (pl)
AU (1) AU2009217201B2 (pl)
BR (1) BRPI0908495A2 (pl)
CA (1) CA2716230C (pl)
CL (1) CL2009000388A1 (pl)
EA (1) EA017737B1 (pl)
ES (1) ES2454366T3 (pl)
IL (1) IL207669A (pl)
MX (1) MX2010009228A (pl)
PE (1) PE20091398A1 (pl)
PL (1) PL2098526T3 (pl)
WO (1) WO2009103176A1 (pl)
ZA (1) ZA201005704B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125898B2 (en) 2008-11-14 2015-09-08 Neurotune Ag Acetam derivatives for pain relief
EP2665729B1 (en) * 2011-01-19 2015-04-01 Convergence Pharmaceuticals Limited Piperazine derivatives as cav2.2 calcium channel blockers
US8648074B2 (en) 2011-09-29 2014-02-11 Abbvie Inc. Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockers
US8669255B2 (en) 2011-09-29 2014-03-11 Abbvie Inc. Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers
CN105008361A (zh) 2012-12-12 2015-10-28 艾伯维公司 作为钙通道阻滞剂用于治疗疼痛的的二氮杂*衍生物
HUE041734T2 (hu) 2014-03-07 2019-05-28 Hoffmann La Roche Új, 6-tagú gyûrûvel kondenzált heteroarildihidropirimidinek hepatitisz B vírusfertõzés kezelésére és megelõzésére
KR102139708B1 (ko) 2015-03-16 2020-07-31 에프. 호프만-라 로슈 아게 Tlr7 작용제 및 hbv 캡시드 조립 억제제를 사용하는 병용 치료
CN109715214B (zh) 2016-09-13 2022-03-04 豪夫迈·罗氏有限公司 Tlr7激动剂和hbv衣壳组装抑制剂的组合治疗
JOP20190251A1 (ar) 2017-05-31 2019-10-21 Metys Pharmaceuticals AG تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
MX2021006248A (es) 2018-12-04 2021-08-11 Metys Pharmaceuticals AG Composiciones sinergicas que comprenden r-2-(sulfonil sustituido)-hexahidro-pirrolo[1,2-a]pirazin-6(2h)-onas y s-2-(sulfonil sustituido)-hexahidro-pirrolo[1,2-a]pirazin-6(2h)-on as en una proporcion no racemica.
BR112021010739A2 (pt) 2018-12-04 2021-08-24 Metys Pharmaceuticals AG Composições sinérgicas compreendendo (r)-(2-(2-oxopirrolidina-1-il)butanamida e (s)-2-(2-oxopirrolidina-1-il)butanamida) em uma proporção não racêmica
KR20210136078A (ko) 2019-03-25 2021-11-16 에프. 호프만-라 로슈 아게 Hbv 코어 단백질 알로스테릭 조절제 화합물의 고체 형태

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3225077A (en) 1963-03-05 1965-12-21 American Cyanamid Co N-cyanoimidates and processes for preparing same
JP3058945B2 (ja) * 1990-10-26 2000-07-04 三共株式会社 N−(3,3−ジ置換アクリロイル)ピペラジン誘導体
US5925648A (en) 1997-07-29 1999-07-20 Schering Corporation Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase
EP1118612A1 (en) 2000-01-21 2001-07-25 Universita Degli Studi di Firenze Piperazine derivatives possesing nootropic activity
BRPI0511295A (pt) * 2004-05-18 2007-12-04 Schering Corp 2-quinolil-oxazóis substituìdos úteis como inibidores de pde4
CA2621564C (en) * 2005-09-09 2014-06-03 Smithkline Beecham Corporation Pyridine derivatives and their use in the treatment of psychotic disorders
AR057828A1 (es) * 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica

Also Published As

Publication number Publication date
MX2010009228A (es) 2010-11-12
EA017737B1 (ru) 2013-02-28
IL207669A0 (en) 2010-12-30
EA201001344A1 (ru) 2011-02-28
AR070465A1 (es) 2010-04-07
CA2716230A1 (en) 2009-08-27
PE20091398A1 (es) 2009-10-13
EP2098526B1 (en) 2014-01-15
JP2011512365A (ja) 2011-04-21
CL2009000388A1 (es) 2010-02-19
CA2716230C (en) 2016-11-01
IL207669A (en) 2014-08-31
BRPI0908495A2 (pt) 2019-09-24
US20110015200A1 (en) 2011-01-20
CN101945876A (zh) 2011-01-12
EP2098526A1 (en) 2009-09-09
ZA201005704B (en) 2013-01-30
WO2009103176A1 (en) 2009-08-27
ES2454366T3 (es) 2014-04-10
AU2009217201A1 (en) 2009-08-27
AU2009217201B2 (en) 2013-06-20
US8334286B2 (en) 2012-12-18
JP5400804B2 (ja) 2014-01-29
CN101945876B (zh) 2014-04-30

Similar Documents

Publication Publication Date Title
IL207669A0 (en) Nitrogen-containing bicyclic compounds active on chronic pain conditions
EP2141990A4 (en) ACTIVE COMPOUNDS ON 11BETA-HSD1
EP2320907A4 (en) THERAPEUTIC COMPOUNDS
EP2351743A4 (en) BICYCLIC CONNECTION
HK1163676A1 (en) Bicyclic heterocyclic compound
EP2211620A4 (en) THERAPEUTIC COMPOUNDS
EP2268285A4 (en) THERAPEUTIC COMPOUNDS
HK1255227A1 (zh) 疼痛治療
GB0806794D0 (en) Therapeutic compounds
GB0813087D0 (en) Therapeutic compounds
GB0716532D0 (en) Therapeutic compounds
GB0813740D0 (en) Therapeutic compounds
IL209318A0 (en) Bicyclic compounds having activity at the cxcr4 receptor
IL200165A0 (en) Compounds that inhibit cholinesterase
EP2164324A4 (en) THERAPEUTIC COMPOUNDS
GB0804755D0 (en) Therapeutic compounds
IL199771A0 (en) Active substance combination
EP2185568A4 (en) THERAPEUTIC COMPOUNDS
GB0819312D0 (en) Active session search
IL180862A0 (en) Temozolomide storage system
GB0702862D0 (en) Therapeutic compounds
IL218495A0 (en) Theraputic agent for chronic pain
ZA201007839B (en) Therapeutic agent for pain
GB0708188D0 (en) Therapeutic compounds
TH104299B (th) สารประกอบไบไซคลิกที่มีไนโตรเจนซึ่งออกฤทธิ์ต่อภาวะเจ็บปวดเรื้อรัง